Women Can Safely Interrupt Endocrine Tx to Pursue Pregnancy

Interrupting endocrine therapy may allow three quarters of women with hormone receptor positive breast cancer to achieve pregnancy, while having no impact on their short-term outcomes, new data suggest.

Related Keywords

New York , United States , Boston , Massachusetts , Houston , Texas , Dana Farber Cancer Institute , America , Ann Partridge , Jenniferk Litton , Marleeni Meyers , University Of Texas Md Anderson Cancer Center , International Breast Cancer Study Group , Partners Foundation , Alliance For Clinical Trials In Oncology , Harvard Medical School , Langone Perlmutter Cancer Center , Breast International Group , Clinical Research , San Antonio Breast Cancer Symposium , Perlmutter Cancer Center , New York City , Cancer Center , Clinical Trials , North America , Breast Cancer , Alignant Breast Neoplasm , Pregnancy , Cancer , Alignant Neoplasia , Arcinoma , Breast , Breast Feeding , Endocrine Therapy , Biologic Therapy , Birth , Birth Defects , Low Birth Weight , Receptors , Fertility , Aromatase Inhibitor , Exemestane , Chemotherapy , Children , Child , Childhood , Ediatrics , Kids , Neoadjuvant , Assisted Reproductive Technology , Body Mass Index Bmi I ,